Feasibility Trial of Prolonged versus Single-Dose Challenge in Penicillin Allergy
NEJM Evidence · 2026
DOI: 10.1056/evidoa2500038 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, 2026. Verfasst von Morgan Rose und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, VIC, Australia. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Amoxicillin, Penicillins, Anti-Bacterial Agents. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, VIC, Australia.
- The Peter Doherty Institute for Infection and Immunity, Department of Infectious Diseases, University of Melbourne, Melbourne, VIC, Australia.
- Department of Infectious Diseases, Peter MacCallum Cancer Centre, National Centre for Infections in Cancer, Melbourne, VIC, Australia.
- National Allergy Centre of Excellence, Parkville, VIC, Australia.
- Department of Infectious Diseases, St George Hospital, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Kogarah, NSW, Australia.
- Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Zitieren
APA
Rose, M., Vogrin, S., Mitri, E. A., De Luca, J., Lapirow, D., Reynolds, G. K., Hall, R., McInnes, K., James, F., Ng, I., Sullivan, R., Lane, M., Legg, A., Copaescu, A., Goh, M. S., Chua, K. Y. L., Holmes, N. E., & Trubiano, J. A. (2026). Feasibility Trial of Prolonged versus Single-Dose Challenge in Penicillin Allergy. NEJM Evidence. https://doi.org/10.1056/evidoa2500038
Vancouver
Rose M, Vogrin S, Mitri EA, De Luca J, Lapirow D, Reynolds GK, et al. Feasibility Trial of Prolonged versus Single-Dose Challenge in Penicillin Allergy. NEJM Evidence. 2026. doi:10.1056/evidoa2500038
BibTeX
@article{Rose2026,
author = {Rose, Morgan and Vogrin, Sara and Mitri, Elise A and De Luca, Joseph and Lapirow, Daniel and Reynolds, Gemma K and Hall, Rebecca and McInnes, Kerryn and James, Fiona and Ng, Irvin and Sullivan, Richard and Lane, Michael and Legg, Amy and Copaescu, Ana and Goh, Michelle S and Chua, Kyra Y L and Holmes, Natasha E and Trubiano, Jason A},
title = {Feasibility Trial of Prolonged versus Single-Dose Challenge in Penicillin Allergy},
journal = {NEJM Evidence},
year = {2026},
doi = {10.1056/evidoa2500038}
}
EUVIMED